Ropirio Therapeutics
Pre-clinicalRopirio Therapeutics develops small molecule therapies targeting RNA-binding proteins for cancer treatment.
Founded
2021
Focus
OncologySmall Molecules
About
Ropirio Therapeutics develops small molecule therapies targeting RNA-binding proteins for cancer treatment.
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile